NEW YORK (360Dx) – Increased follow-up surveillance of patients treated for colorectal cancer did not significantly improve their outcomes, researchers said in a pair of studies published on Tuesday in the Journal of the American Medical Association.

Together, the studies cast a new light on how aggressively colorectal cancer patients should be tested with multislice contrast-enhanced CT of the thorax and abdomen, and serum carcinoembryonic antigen (CEA) following treatment, and whether guidelines for follow-up care need to be reconsidered.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.